Investing Profile

Peter Dudek

InvestorVC
President & Managing Partner, MRL Ventures Fund at Merck
mrlv.comCambridge, Massachusetts
Photo of Peter Dudek, President at MRL Ventures Fund
cb
$15.0M - $20.0M
$17.5M
5
CompanyStageDateRound SizeTotal Raised
Carisma Therapeutics
Series CSep 2022$30M
Series BMar 2021$12M
$150M
Co-investors: Margarita Chavez (AbbVie Ventures), Dr. Regina Hodits (Wellington Partners), Geeta Vemuri (Agent Capital)
Mozart Therapeutics
Series AOct 2021$55M
$55M
Co-investors: Lucio Iannone (Leaps by Bayer), Henrijette Richter (Soffinova Partners), Steven Gillis (ARCH Venture Partners)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$330M
Co-investors: Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Nancy Hong (RiverVest), Andrew Hack (Bain Capital Life Sciences), Jack Kenney (SV Health Investors)